Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition

• Published in: International journal of molecular sciences Vol. 21; no. 21; p. 8105
• Main Authors: Montalvo, Ryan N, Doerr, Vivian, Kwon, Oh Sung, Talbert, Erin E, Yoo, Jeung-Ki, Hwang, Moon-Hyon, Nguyen, Branden L, Christou, Demetra D, Kavazis, Andreas N, Smuder, Ashley J
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 30-10-2020; MDPI AG
• Subjects: adriamycin; Animals; anthracycline; Antibiotics, Antineoplastic - toxicity; Autophagy; Autophagy-Related Protein 5 - genetics; Autophagy-Related Protein 5 - metabolism; cardiotoxicity; Cardiotoxicity - etiology; Cardiotoxicity - pathology; Cardiotoxicity - prevention & control; chemotherapy; Doxorubicin - toxicity; Male; Membrane Potential, Mitochondrial; oxidative stress; Oxidative Stress - drug effects; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species - metabolism; Signal Transduction; cardiotoxicity; anthracycline; chemotherapy; oxidative stress; adriamycin
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms21218105

Doxorubicin (DOX) is a highly effective chemotherapeutic agent used in the treatment of various cancer types. Nevertheless, it is well known that DOX promotes the development of severe cardiovascular complications. Therefore, investigation into the underlying mechanisms that drive DOX-induced cardiotoxicity is necessary to develop therapeutic countermeasures. In this regard, autophagy is a complex catabolic process that is increased in the heart following DOX exposure. However, conflicting evidence exists regarding the role of autophagy dysregulation in the etiology of DOX-induced cardiac dysfunction. This study aimed to clarify the contribution of autophagy to DOX-induced cardiotoxicity by specifically inhibiting autophagosome formation using a dominant negative autophagy gene 5 (ATG5) adeno-associated virus construct (rAAV-dnATG5). Acute (2-day) and delayed (9-day) effects of DOX (20 mg/kg intraperitoneal injection (i.p.)) on the hearts of female Sprague-Dawley rats were assessed. Our data confirm established detrimental effects of DOX on left ventricular function, redox balance and mitochondrial function. Interestingly, targeted inhibition of autophagy in the heart via rAAV-dnATG5 in DOX-treated rats ameliorated the increase in mitochondrial reactive oxygen species emission and the attenuation of cardiac and mitochondrial function, but only at the acute timepoint. Deviation in the effects of autophagy inhibition at the 2- and 9-day timepoints appeared related to differences in ATG5-ATG12 conjugation, as this marker of autophagosome formation was significantly elevated 2 days following DOX exposure but returned to baseline at day 9. DOX exposure may transiently upregulate autophagy signaling in the rat heart; thus, long-term inhibition of autophagy may result in pathological consequences.